CytaCoat is developing a new technology of antibacterial coating for medical devices. CytaCoat AB is a private Swedish company located in the Karolinska Institutet Science Park AB in Solna (Stockholm area). The company was founded by a group of researchers from the Karolinska Institute, one of the foremost medical universities in the world, and theRoyal Institute of Technology (KTH). It was a special purpose vehicle started with a goal to develop a new technology of antibacterial coating for medical devices. It was based on a discovery that their proprietary polymer surface exhibits a clear effect on several of the most problematic pathogenic bacteria that pose problems in healthcare today. Since then, the company has been focused on transforming this innovation into a fully viable commercial product and make it available through licenses.CytaCoat has a fully equipped laboratory in the Karolinska Institutet Science Park, where both microbiology evaluation, optimisation of the CytaCoat technology and a pilot plant production can be performed. The company has also established contacts with clinical collaborators at Karolinska University Hospital Neonatal Unit and the Division of Clinical Microbiology. CytaCoat has also been cooperating with experienced consultants in regulatory, clinical research organisations, patent experts and providers of specialist analyses.

Biotechnology

Health Care

CytaCoat

The Solna office focuses on leadership, product strategy, and chemical production within the Stockholm area.

Solna

Graeme Brookes

Per Wirsén

Jacob Odeberg

Birgitta Agerberth

Markus Fagerlund

Ana Romero

Jan Andersson

Peter Hentschel

Tomas Kramar

Alan Rhodes

The Directors and Advisors team at CytaCoat provides strategic leadership and guidance to ensure the company's development of its antibacterial coating technology aligns with both scientific and commercial objectives. They oversee strategic partnerships, regulatory compliance, and clinical collaborations, leveraging their expertise to drive the company's growth and successful market entry.

Directors and Advisors

The Leadership Team at CytaCoat is responsible for steering the strategic direction of the company, overseeing operational execution, fostering innovation, and ensuring the successful commercialization of its antibacterial coating technology for medical devices. This team, composed of the Chief Executive Officer, Chief Operating Officer, and the company's co-founders, collaborates closely with clinical, regulatory, and industry experts to drive growth and establish CytaCoat's footprint in the healthcare market.

Leadership Team

The Research and Development team at CytaCoat focuses on innovating and refining the company's antibacterial coating technology for medical devices. Comprising microbiologists and chemists, the team conducts microbiology evaluations, optimizes the polymer surface technology, and oversees pilot plant production to ensure the product's efficacy and safety. Their work is integral to transforming research discoveries into a viable commercial product ready for market licensing.

Research and Development

This department oversees the strategic direction and governance of the organization.

Board Leadership

This department focuses on identifying and developing strategies for new market opportunities and product offerings.

CytaCoat

Org chart

Board & advisors

Teams

Directors and Advisors

Leadership Team

Research and Development

Board Leadership

Market Strategy

Offices

CytaCoat

Org chart

Board & advisors

Teams

Directors and Advisors

Leadership Team

Research and Development

Board Leadership

Market Strategy

Offices

Related companies